Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy

Anand, 2005, Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT, Circulation, 112, 1121, 10.1161/CIRCULATIONAHA.104.512988 Mullens, 2009, Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program, J Am Coll Cardiol, 53, 765, 10.1016/j.jacc.2008.11.024 Venkateswaran, 2015, Anemia and its association with clinical outcome in heart failure patients undergoing cardiac resynchronization therapy, J Interv Card Electrophysiol, 44, 297, 10.1007/s10840-015-0062-9 Kazory, 2009, Anemia: the point of convergence or divergence for kidney disease and heart failure?, J Am Coll Cardiol, 53, 639, 10.1016/j.jacc.2008.10.046 Rickard, 2012, Elevated red cell distribution width is associated with impaired reverse ventricular remodeling and increased mortality in patients undergoing cardiac resynchronization therapy, Congest Heart Fail, 18, 79, 10.1111/j.1751-7133.2011.00267.x Jankowska, 2010, Iron deficiency: an ominous sign in patients with systolic chronic heart failure, Eur Heart J, 31, 1872, 10.1093/eurheartj/ehq158 Anker, 2009, Ferric carboxymaltose in patients with heart failure and iron deficiency, N Engl J Med, 361, 2436, 10.1056/NEJMoa0908355 Ponikowski, 2015, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger, Eur Heart J, 36, 657, 10.1093/eurheartj/ehu385 Dong, 2005, Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration, Clin Sci (Lond), 109, 277, 10.1042/CS20040278 Naito, 2009, Adaptive response of the heart to long-term anemia induced by iron deficiency, Am J Physiol Heart Circ Physiol, 296, H585, 10.1152/ajpheart.00463.2008 Turner, 2002, Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy, BMC Physiol, 2, 1, 10.1186/1472-6793-2-1 McMurray, 2012, Eur J Heart Fail, 14, 803, 10.1093/eurjhf/hfs033 Mullens, 2011, Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy, Am J Cardiol, 108, 409, 10.1016/j.amjcard.2011.03.060 Okonko, 2008, Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial, J Am Coll Cardiol, 51, 103, 10.1016/j.jacc.2007.09.036 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Jankowska, 2013, Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives, Eur Heart J, 34, 816, 10.1093/eurheartj/ehs224 Verbrugge, 2012, Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling, J Card Fail, 18, 845, 10.1016/j.cardfail.2012.09.003 Melman, 2015, Circulating MicroRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study, Circulation, 131, 2202, 10.1161/CIRCULATIONAHA.114.013220 Munzel, 2015, Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications, Eur Heart J, 36, 2555, 10.1093/eurheartj/ehv305 DeMazumder, 2015, Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling, Circ Res, 116, 1691, 10.1161/CIRCRESAHA.116.305268 Lichter, 2014, Remodeling of the sarcomeric cytoskeleton in cardiac ventricular myocytes during heart failure and after cardiac resynchronization therapy, J Mol Cell Cardiol, 72, 186, 10.1016/j.yjmcc.2014.03.012 Kirk, 2014, Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3beta, J Clin Invest, 124, 129, 10.1172/JCI69253 Aiba, 2013, Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure, Circ Arrhythm Electrophysiol, 6, 546, 10.1161/CIRCEP.113.000400 Chakir, 2011, Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart, Sci Transl Med, 3, 100ra88, 10.1126/scitranslmed.3001909 Wang, 2011, Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy, Circ Res, 109, 750, 10.1161/CIRCRESAHA.111.246124 Agnetti, 2010, Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts, Circ Cardiovasc Genet, 3, 78, 10.1161/CIRCGENETICS.109.871236 Vanderheyden, 2008, Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders, J Am Coll Cardiol, 51, 129, 10.1016/j.jacc.2007.07.087 Usmanov, 2008, Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency, J Nephrol, 21, 236 Toblli, 2007, Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency, J Am Coll Cardiol, 50, 1657, 10.1016/j.jacc.2007.07.029 Jankowska, 2011, Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure, J Card Fail, 17, 899, 10.1016/j.cardfail.2011.08.003